Treace Medical Concepts, Inc. Payments to Acquire Marketable Securities
Treace Medical Concepts, Inc. (TMCI) reported Payments to Acquire Marketable Securities of $140.07 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Cash Flow
us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2023-11-09
- Treace Medical Concepts, Inc. payments to acquire marketable securities for the quarter ending 2023-09-30 was $19.12M.
- Treace Medical Concepts, Inc. payments to acquire marketable securities for the quarter ending 2022-09-30 was $0.00.
| Period end | Payments to Acquire Marketable Securities 3 month | Payments to Acquire Marketable Securities 6 month | Payments to Acquire Marketable Securities 9 month |
|---|---|---|---|
| 2023-09-30 | $19.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $140.07M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $120.96M 10-Q · filed 2023-08-09 | ||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $0.00 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |